Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1998) 1998
Newspaper Article (971) 971
Publication (505) 505
Paper (470) 470
Patent (156) 156
Report (109) 109
Book / eBook (40) 40
Book Chapter (24) 24
Conference Proceeding (24) 24
Magazine Article (23) 23
Dissertation (14) 14
Web Resource (10) 10
Book Review (7) 7
Data Set (4) 4
Streaming Audio (4) 4
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (603) 603
experiment (505) 505
cern lhc coll (466) 466
experimental results (464) 464
high energy physics - experiment (464) 464
particle physics (428) 428
cms (418) 418
humans (401) 401
physics - high energy physics - experiment (362) 362
high energy physics (357) 357
p p: scattering (321) 321
p p: colliding beams (286) 286
physics of elementary particles and fields (274) 274
physics, particles & fields (226) 226
oncology (222) 222
particle physics - experiment (219) 219
phenomenology (212) 212
hadron-hadron scattering (207) 207
8000 gev-cms (202) 202
scattering [p p] (193) 193
female (175) 175
male (168) 168
nuclear experiment (159) 159
13000 gev-cms (150) 150
colliding beams [p p] (146) 146
index medicus (145) 145
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (134) 134
lung neoplasms - drug therapy (130) 130
middle aged (130) 130
background (123) 123
aged (114) 114
adult (107) 107
astronomy & astrophysics (104) 104
elementary particles, quantum field theory (101) 101
quantum field theories, string theory (101) 101
carcinoma, non-small-cell lung - drug therapy (99) 99
supersymmetry (98) 98
lung neoplasms - pathology (93) 93
classical and quantum gravitation, relativity theory (83) 83
human necessities (83) 83
quantum physics (83) 83
hep (81) 81
astrophysics (80) 80
chemistry (80) 80
hygiene (77) 77
medical or veterinary science (77) 77
metallurgy (76) 76
physics, nuclear (74) 74
preparations for medical, dental, or toilet purposes (72) 72
instrumentation and detectors (71) 71
lung cancer (71) 71
respiratory system (69) 69
animals (68) 68
rapidity dependence (67) 67
transverse momentum dependence (63) 63
ex (62) 62
final state:jet lepton (62) 62
high energy astrophysical phenomena (60) 60
lung neoplasms - genetics (60) 60
transverse momentum: missing-energy (60) 60
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (58) 58
cern lab (58) 58
chemotherapy (58) 58
collisions (58) 58
nuclear and high energy physics (56) 56
channel cross section: upper limit (55) 55
mass dependence (55) 55
analysis (54) 54
physics and astronomy (53) 53
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
114 physical sciences (51) 51
large hadron collider (51) 51
carcinoma, non-small-cell lung - pathology (50) 50
data analysis method (50) 50
kinematics (50) 50
top: pair production (50) 50
7000 gev-cms (48) 48
biochemistry (48) 48
física (48) 48
microbiology (48) 48
neoplasm staging (48) 48
quantum chromodynamics: perturbation theory (48) 48
sensitivity (48) 48
cancer (46) 46
jet: bottom (46) 46
antineoplastic agents - therapeutic use (45) 45
jet: transverse momentum (45) 45
article (44) 44
z0: leptonic decay (44) 44
bottom: particle identification (42) 42
beer (41) 41
enzymology (41) 41
lung neoplasms - therapy (41) 41
mutation or genetic engineering (41) 41
nuclear physics (41) 41
research (41) 41
spirits (41) 41
treatment outcome (41) 41
vinegar (41) 41
wine (41) 41
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (10) 10
Gerstein Science - Stacks (7) 7
Robarts - Stacks (7) 7
Law (Bora Laskin) - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
UofT at Mississauga - Stacks (3) 3
OISE - Children's Literature (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Faculty of Information - Juvenile (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Novelties Reading Area (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3352) 3352
French (61) 61
German (25) 25
Spanish (10) 10
Portuguese (8) 8
Chinese (2) 2
Finnish (2) 2
Irish (2) 2
Japanese (2) 2
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Robert Comis, MD, The Passing of a “Lung Man”
by Bunn, Paul A
Journal of Thoracic Oncology, ISSN 1556-0864, 08/2017, Volume 12, Issue 8, pp. 1323 - 1324
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Targeting epidermal growth factor receptor-tyrosine kinase in the most common solid tumors
by Bunn, Paul A and Arteaga, Carlos L
2003, Seminars in oncology, Volume 30, no. 1, suppl. 1., 55
Book
Details down arrow
3. Taxol
: Fortschritte bei der Behandlung des nichtkleinzelligen Bronchialkarzinoms
by Bunn, Paul A and Le Chevalier, T
1999, Aktuelle Onkologie, ISBN 9783886036660, Volume 104., v, 76
Book
Details down arrow
4. Current topics in lung cancer
by Bunn, Paul A
1991, Monographs / European School of Oncology, ISBN 9783540543015, 82
Lungs | Lung Neoplasms | therapy | Cancer
Book
Details down arrow
5. Full Text New and emerging targeted treatments in advanced non-small-cell lung cancer
by Hirsch, Fred R, Prof and Suda, Kenichi, MD and Wiens, Jacinta, PhD and Bunn, Paul A, MD
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10048, pp. 1012 - 1024
Summary Targeted therapies are substantially changing the management of lung cancers. These treatments include drugs that target driver mutations, those that... 
Internal Medicine | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CISPLATIN PLUS GEMCITABINE | MULTICENTER PHASE-II | ADULT PATIENTS PTS | ACQUIRED-RESISTANCE | OPEN-LABEL | EGFR MUTATIONS | GROWTH-FACTOR | SINGLE-ARM | CLINICAL ACTIVITY | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Translocation, Genetic | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Proto-Oncogene Proteins - genetics | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Molecular Targeted Therapy | Protein-Tyrosine Kinases - genetics | Receptor Protein-Tyrosine Kinases - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Lung cancer, Non-small cell | Medical research | Chemotherapy | Lung cancer | Cytotoxicity | Kinases | Vascular endothelial growth factor | Cancer therapies | Patients
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Recent clinical advances in lung cancer management
by Johnson, David H and Johnson, David H and Schiller, Joan H and Schiller, Joan H and Bunn Jr, Paul A and Bunn Jr, Paul A
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 973 - 982
Progress in lung cancer therapy has been slow but steady and has accelerated due to improvements in scientific basis for the disease and to technologic... 
PHASE-III TRIAL | PROPHYLACTIC CRANIAL IRRADIATION | CISPLATIN PLUS GEMCITABINE | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | PLATINUM-BASED CHEMOTHERAPY | SMALL-CELL CARCINOMA | INTERNATIONAL-ASSOCIATION | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | PREDICTIVE GENE SIGNATURE | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Early Detection of Cancer | Humans | Lung Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - diagnosis | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - therapy | Genes, erbB-1 | Small Cell Lung Carcinoma - pathology | Small Cell Lung Carcinoma - therapy | Lung Neoplasms - diagnosis | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Small cell lung cancer
: etiology, biology, clinical features, staging, and treatment
by Cook, Robert M and Miller, York E and Bunn, Paul A
1993, Volume 17, no. 2., 71-141.
Book
Details down arrow
8. Clinical experiences with platinum and etoposide therapy in lung cancer
by Bunn, Paul A and Niitani, H and Saijo, Nagahiro
1992, Oncology, ISBN 9783805556392, Volume 49/S1/92., iv, 80
Book
Details down arrow
9. Full Text Small-cell lung cancer: What we know, what we need to know and the path forward
by Gazdar, Adi F and Bunn, Paul A and Minna, John D
Nature Reviews Cancer, ISSN 1474-175X, 12/2017, Volume 17, Issue 12, pp. 725 - 737
Small-cell lung cancer (SCLC) is a deadly tumour accounting for approximately 15% of lung cancers and is pathologically, molecularly, biologically and... 
BRONCHIAL EPITHELIUM | ENGINEERED MOUSE MODELS | STEM-CELLS | NEUROENDOCRINE TUMORS | DNA METHYLATION | ONCOLOGY | EPIGENETIC INACTIVATION | TUMOR-SUPPRESSOR GENES | POTENTIAL THERAPEUTIC TARGET | CARCINOMA | HISTONE METHYLTRANSFERASE | Signal Transduction | Humans | Receptors, Notch - genetics | Small Cell Lung Carcinoma - genetics | Molecular Targeted Therapy | Small Cell Lung Carcinoma - drug therapy | Tumor Suppressor Protein p53 - genetics | Xenograft Model Antitumor Assays | Small Cell Lung Carcinoma - pathology | Animals | Neurosecretory Systems - metabolism | Mice | Retinoblastoma Binding Proteins - genetics | Ubiquitin-Protein Ligases - genetics | Care and treatment | Lung cancer, Small cell | Development and progression | Genetic aspects | Cellular signal transduction | Gene expression | Health aspects | Oncogenes | Medical research | Animal models | Deactivation | Small cell lung carcinoma | p53 Protein | Lung cancer | Clinical trials | Cytotoxicity | Inactivation | Metastases | Signaling | Molecular modelling | Lungs | Xenografts | Genetic engineering | Notch protein | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Conclusion
by Bunn, Paul A and Thatcher, Nick
Oncologist, ISSN 1083-7159, 2008, Volume 13, Issue 1, pp. 37 - 46
Non-small cell lung carcinoma | Angiogenesis inhibitors protein kinase inhibitors | Antineoplastic agents | Antimetabolites
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
by Weickhardt, Andrew J and Scheier, Benjamin and Burke, Joseph Malachy and Gan, Gregory and Lu, Xian and Bunn, Paul A and Aisner, Dara L and Gaspar, Laurie E and Kavanagh, Brian D and Doebele, Robert C and Camidge, D. Ross
Journal of Thoracic Oncology, ISSN 1556-0864, 12/2012, Volume 7, Issue 12, pp. 1807 - 1814
Many patients with oncogene-driven non–small-cell lung cancer (NSCLC) treated with tyrosine kinase inhibitors experience limited sites of disease progression.... 
anaplastic lymphoma kinase gene arrangement non–small-cell lung cancer | EGFR-mutant non–small-cell lung cancer | Radiation therapy | Oligoprogressive disease | anaplastic lymphoma kinase gene arrangement non-small-cell lung cancer | EGFR-mutant non-small-cell lung cancer | PHASE-I/II TRIAL | ACQUIRED-RESISTANCE | BODY RADIATION-THERAPY | DOSE WEEKLY ERLOTINIB | BREAST-CANCER | LIVER METASTASES | SYNCHRONOUS BRAIN METASTASES | STEREOTACTIC RADIOSURGERY | ONCOLOGY | LEPTOMENINGEAL METASTASES | RESPIRATORY SYSTEM | RECURRENT MALIGNANT GLIOMAS | Erlotinib Hydrochloride | Receptor, Epidermal Growth Factor - genetics | Pyrazoles - therapeutic use | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Catheter Ablation | Lung Neoplasms - pathology | Male | Young Adult | Brain Neoplasms - secondary | Aged, 80 and over | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Mutation - genetics | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Carcinoma, Non-Small-Cell Lung - therapy | Receptor Protein-Tyrosine Kinases - genetics | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Gene Rearrangement | Brain Neoplasms - therapy | Aged | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Robert Comis, MD, The Passing of a "Lung Man"
by Bunn, Jr, Paul A
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 08/2017, Volume 12, Issue 8, p. 1323
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Systemic therapy for elderly patients with advanced non–small-cell lung cancers
by Bunn, Paul A and Dimou, Anastasios
Journal of Clinical Oncology, ISSN 0732-183X, 09/2018, Volume 36, Issue 25, pp. 2571 - 2574
CARBOPLATIN-PACLITAXEL | TRIAL | 1ST-LINE TREATMENT | GEFITINIB | METAANALYSIS | ONCOLOGY | BEVACIZUMAB | PHASE-III | OPEN-LABEL | CHEMOTHERAPY | GEMCITABINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
by Nasser Hanna and Frances A. Shepherd and Frank V. Fossella and Jose R. Pereira and Filippo De Marinis and Joachim von Pawel and Ulrich Gatzemeier and Thomas Chang Yao Tsao and Miklos Pless and Thomas Muller and Hong-Liang Lim and Christopher Desch and Klara Szondy and Radj Gervais and Shaharyar and Christian Manegold and Sofia Paul and Paolo Paoletti and Lawrence Einhorn and Paul A. Bunn Jr
Journal of Clinical Oncology, ISSN 0732-183X, 05/2004, Volume 22, Issue 9, pp. 1589 - 1597
Purpose To compare the efficacy and toxicity of pemetrexed versus docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) previously treated... 
ONCOLOGY | QUALITY-OF-LIFE | Glutamates - therapeutic use | Lung Neoplasms - drug therapy | Glutamates - adverse effects | Guanine - analogs & derivatives | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Taxoids - therapeutic use | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Guanine - adverse effects | Antineoplastic Agents, Phytogenic - therapeutic use | Neutropenia - chemically induced | Guanine - therapeutic use | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Treatment Outcome | Pemetrexed | Taxoids - administration & dosage | Survival Analysis | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Guanine - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Worldwide overview of the current status of lung cancer diagnosis and treatment
by Bunn, Paul A
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 12/2012, Volume 136, Issue 12, pp. 1478 - 1481
Lung cancer is the leading worldwide cause of cancer deaths. Smoking is the dominant cause of lung cancer and smoking cessation is the established method to... 
MEDICINE, RESEARCH & EXPERIMENTAL | 1ST-LINE TREATMENT | MULTICENTER | BEVACIZUMAB | ADENOCARCINOMA | PHASE-III | CLASSIFICATION | OPEN-LABEL | PATHOLOGY | CHEMOTHERAPY | GEMCITABINE | INTERNATIONAL ASSOCIATION | MEDICAL LABORATORY TECHNOLOGY | Smoking - adverse effects | Early Detection of Cancer - trends | Animals | Global Health | Lung Neoplasms - prevention & control | Humans | Smoking - trends | Lung Neoplasms - pathology | Lung Neoplasms - therapy | Neoplasm Staging - trends | Lung Neoplasms - diagnosis | Smoking Cessation | Care and treatment | Smokers | Lung cancer | Diagnostic imaging | Diagnosis | Comparative analysis | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Erratum: Small-cell lung cancer: what we know, what we need to know and the path forward
by Gazdar, Adi F and Bunn, Paul A and Minna, John D
Nature Reviews Cancer, ISSN 1474-175X, 12/2017, Volume 17, Issue 12, pp. 765 - 765
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Increased Epidermal Growth Factor Receptor Gene Copy Number Detected by Fluorescence In Situ Hybridization Associates With Increased Sensitivity to Gefitinib in Patients With Bronchioloalveolar Carcinoma Subtypes: A Southwest Oncology Group Study
by Fred R. Hirsch and Marileila Varella-Garcia and Jason McCoy and Howard West and Ana Carolina Xavier and Paul Gumerlock and Paul A. Bunn Jr and Wilbur A. Franklin and John Crowley and David R. Gandara and Southwest Oncology Group
Journal of Clinical Oncology, ISSN 0732-183X, 10/2005, Volume 23, Issue 28, pp. 6838 - 6845
Purpose Bronchioloalveolar carcinoma (BAC) and adenocarcinomas with BAC features seem to be increasing in incidence, particularly in younger, never-smoking... 
CELL LUNG-CANCER | BREAST-CANCER | PHASE-II TRIAL | AMPLIFICATION | EFFICACY | ONCOLOGY | SAFETY | TYROSINE KINASE | PROTEIN EXPRESSION | MUTATIONS | INHIBITOR | Lung Neoplasms - drug therapy | Predictive Value of Tests | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Adenocarcinoma, Bronchiolo-Alveolar - genetics | Patient Selection | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Receptor, Epidermal Growth Factor - physiology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | In Situ Hybridization, Fluorescence | Treatment Outcome | Gene Dosage | Adenocarcinoma - drug therapy | Genes, erbB-2 | Quinazolines - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma, Bronchiolo-Alveolar - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer
by Doebele, Robert C and Lu, Xian and Sumey, Christopher and Maxson, DeLee A and Weickhardt, Andrew J and Oton, Ana B and Bunn, Paul A and Barón, Anna E and Franklin, Wilbur A and Aisner, Dara L and Varella‐Garcia, Marileila and Camidge, D. Ross
Cancer, ISSN 0008-543X, 09/2012, Volume 118, Issue 18, pp. 4502 - 4511
BACKGROUND: The discovery of distinct subsets of nonsmall cell lung cancer (NSCLC) characterized by activation of driver oncogenes has greatly affected... 
anaplastic lymphoma kinase tyrosine kinase receptor | metastasis | nonsmall cell lung cancer | epidermal growth factor receptor | Kirsten rat sarcoma viral oncogene | CARBOPLATIN | GEFITINIB | PHASE-III | PACLITAXEL | GENE | ONCOLOGY | NEVER-SMOKERS | MUTATIONS | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Liver Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Male | Proto-Oncogene Proteins - genetics | Neoplasm Metastasis - genetics | Receptor Protein-Tyrosine Kinases - genetics | Gene Rearrangement | Female | Genes, ras | Liver Neoplasms - secondary | Oncogenes | Lung cancer, Non-small cell | Care and treatment | Metastasis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights